Skip to content

Crinetics Pharmaceuticals CRNX Employee Benefit Trust

Employee Benefit Trust at other companies

CHE
ChemedCHE
$2.3M+4.5%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$1.03M
RLI logo
RLIRLI
$11.54M-2.3%
Independent Bank Corp logo
Independent Bank CorpINDB
$3.62M+2.8%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$23.91M
Assured Guaranty logo
Assured GuarantyAGO
$1M0.0%

Other financials

Income statement

See full
Revenue$10.7M+2,873%
Gross profit$10.5M+2,818%
Operating income-$140.4M-26.0%
Net income-$127.8M-32.1%
EPS (diluted)-$1.23-18.3%

Balance sheet

See full
Cash & equivalents$115.1M+20.1%
Total debt$47.9M-5.8%
Total equity$1.3B+2.1%
Total assets$1.4B+2.9%

Cash flow

See full
Operating cash flow-$124.7M-41.0%
CapEx$820.0K-33.8%
Free cash flow-$125.5M-40.0%

Valuation

See full
Market cap$3.79B+21.9%

Profitability

See full
Gross margin150%-15.6pp
Operating margin-3,020.3%-1,463pp
Net margin-2,747.2%-1,328pp
FCF margin-2,321.7%-1,122pp

Returns & leverage

See full
Return on equity-39.2%+14.5pp
Debt / equity0.0×
Current ratio18.6×-3.9×

Where this comes from

Reported directly by Crinetics Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesHeldInEmployeeTrust.

The official record: Crinetics Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Crinetics Pharmaceuticals's employee benefit trust.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Crinetics Pharmaceuticals's employee benefit trust?
Crinetics Pharmaceuticals (CRNX) reported employee benefit trust of $1.03M in Q1 2026.
What does employee benefit trust mean?
This represents the value of assets held in a trust specifically designated to fund employee benefit programs or equity-based compensation plans. It functions as a mechanism to align employee interests with long-term shareholder value through deferred compensation structures. Changes in this balance reflect the company's strategy for talent retention and the funding status of its benefit obligations.